Coeptis Therapeutics Holdings, INC. (COEPW) SEC Filings — 2024

Filings

• Coeptis Therapeutics Files 8-K with Bylaw Amendments — 8-K · Dec 27, 2024
• Coeptis Therapeutics Stockholders to Vote on Share Increase — 8-K · Dec 20, 2024
• Coeptis Therapeutics Raises $1.5M Via Convertible Notes — 8-K · Dec 17, 2024
• Coeptis Therapeutics CMO Resigns; Interim Appointed — 8-K · Dec 4, 2024
• Coeptis Therapeutics Holdings, INC. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• Coeptis Therapeutics Files Definitive Proxy Statement — DEF 14A · Nov 14, 2024
• Coeptis Therapeutics Files Q3 2024 10-Q — 10-Q · Nov 13, 2024
• Coeptis Therapeutics Enters Material Definitive Agreement — 8-K · Nov 6, 2024
• Coeptis Therapeutics Files 8-K: Accountant Change & Financials — 8-K · Sep 30, 2024
• Coeptis Therapeutics Faces Delisting Notice — 8-K · Sep 19, 2024
• Coeptis Therapeutics Files 2023 10-K/A with Restated Financials — 10-K/A · Aug 16, 2024
• Coeptis Therapeutics Restates Financials Due to Accounting Review — 8-K · Aug 14, 2024
• Coeptis Therapeutics Faces Nasdaq Delisting Warning — 8-K · Jul 31, 2024
• Coeptis Therapeutics Raises $1.5M in Private Placement — 8-K · Jun 20, 2024
• Coeptis Therapeutics Holdings, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 10, 2024
• Coeptis Therapeutics Holdings, Inc. Files 2023 10-K — 10-K · Mar 26, 2024
• Coeptis Therapeutics Files 10-K/A Amendment to Restate 2022 Financials — 10-K/A · Mar 25, 2024
• Coeptis Therapeutics Holdings, INC. SC 13G Filing — SC 13G · Feb 14, 2024
• COEPTIS THERAPEUTICS FACES DELISTING THREAT — 8-K · Feb 1, 2024